Advertisement

Topics

Cambridge NeuroScience Incorporated Company Profile

00:33 EST 23rd November 2017 | BioPortfolio

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the nervous system.

Cambridge NeuroScience is focused in two areas of research and development: (i) ion-channel blockers to prevent or treat brain damage resulting from stroke and other forms of brain ischemia, as well as for the treatment or prevention of neuropathic pain, glaucoma, spinal cord injury, Parkinson's disease, multiple sclerosis ("MS") and peripheral neuropathies, and (ii) growth factors for the treatment of MS and peripheral neuropathies.

Location

333 Providence Highway
Norwood
MA
02062
United States of America

Contact

Phone: 781-255-6700
Fax: 781-255-6711


News Articles [526 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Paramount Recruitment: Research Engineer – Neuroscience – Cambridge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Research Engineer – Neuroscience – Cambrid...

#jobs #lifescience Paramount Recruitment: Senior Research Engineer – Neuroscience – Cambridge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Senior Research Engineer – Neuroscience – ...

Cambridge Epigenetix and NuGEN begin collaboration

Cambridge Epigenetix, a spin-out from the University of Cambridge, has entered into a partnership to…

Investors Venture Boldly Into Neuroscience

Neuroscience startups have seen an uptick in funding in recent years. There are several reasons why.

Why Neuroscience Is the Key To Innovation in AI

The future of AI lies in neuroscience. So says Google DeepMind’s founder Demis Hassabis in a review paper published last week in the prestigious journal Neuron. Hassabis is no stranger to both field...

Cambridge Cognition launches web-based testing using digital cognitive markers for virtual research

The neuroscience digital health company Cambridge Cognition Holdings PLC, which develops and markets software products to improve brain health worldwide, today announced the launch of a new web-based ...

Innovations in neuroscience sector

Neuroscience has been at the forefront of advancing technologies, adapting new techniques and devices successfully in an effort to increase the safety, efficacy of brain and spine treatment.

Study: More neuroscience research articles are reporting the sex of laboratory animals

(North Carolina State University) In the largest-ever survey of neuroscience research, scientists found that the number of research studies reporting the sex of lab animals increased significantly in ...

PubMed Articles [758 Associated PubMed Articles listed on BioPortfolio]

What is important in transdisciplinary pain neuroscience education? A qualitative study.

The main focus of Pain Neuroscience Education is around changing patients' pain perceptions and minimizing further medical care. Even though Pain Neuroscience Education has been studied extensively, t...

Defining Neuroscience Nursing.

Corrigendum to "Osteopontin-metallothionein I/II interactions in experimental autoimmune encephalomyelitis" Neuroscience 350 (2017) 133-145.

On Open Access, Special Issues and Strategies for Increasing the Readership of your Neuroscience Research.

Buildings, Beauty, and the Brain: A Neuroscience of Architectural Experience.

A burgeoning interest in the intersection of neuroscience and architecture promises to offer biologically inspired insights into the design of spaces. The goal of such interdisciplinary approaches to ...

Clinical Trials [89 Associated Clinical Trials listed on BioPortfolio]

Precision Psychiatry Continuity Clinic Project

This is a demonstration project focused on translating neuroscience insights into clinical practice. The researchers will evaluate how neuroscience assessments may be applied in the clinic...

Pain Neuroscience Education in Healthy Children

The primary objective of this study is to examine whether Pain Neuroscience Education for children is able to increase a child's knowledge on the neurophysiology of pain. In addition, thi...

Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial

The primary objective of this study is to provide duloxetine to investigators for the treatment of patients who have previously participated in neuroscience duloxetine clinical trials and ...

Effects of Oral Care in the Neuroscience ICU

The purpose of this study is to compare how effective different ways of mouth cleaning are for patients in a neuroscience intensive care unit with a breathing tube in their mouth.

Pain Processing and Pain Neuroscience Education in Children With Chronic Abdominal Pain

The primary scientific objective of the study entails examining whether altered endogenous pain inhibition is present in children with functional abdominal pain (FAP) and irritable bowel s...

Companies [540 Associated Companies listed on BioPortfolio]

Cambridge NeuroScience Incorporated

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the ...

Neurovance Inc.

Neurovance is a neuroscience-focused, clinical-stage biopharmaceutical company that specializes in triple reuptake inhibitors specifically optimized for adult attention deficit hy...

Abcam

Abcam is a producer and distributor of research-grade antibodies and associated products, headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office locate...

Abcam plc

Abcam is a producer and distributor of research-grade antibodies and associated products, headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office locate...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Prox...

More Information about "Cambridge NeuroScience Incorporated" on BioPortfolio

We have published hundreds of Cambridge NeuroScience Incorporated news stories on BioPortfolio along with dozens of Cambridge NeuroScience Incorporated Clinical Trials and PubMed Articles about Cambridge NeuroScience Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge NeuroScience Incorporated Companies in our database. You can also find out about relevant Cambridge NeuroScience Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record